These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8188900)

  • 1. Noninvasive measurement of arterial blood plasma concentration of iodinated contrast agents from CT scans of human brain.
    Lapin GD; Allen CV; Groothuis DR
    J Comput Assist Tomogr; 1994; 18(3):363-9. PubMed ID: 8188900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive CT determination of arterial blood concentration of meglumine iothalamate.
    Lapin GD; Munson RJ; Groothuis DR
    J Comput Assist Tomogr; 1993; 17(1):108-14. PubMed ID: 8419417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography.
    Groothuis DR; Lapin GD; Vriesendorp FJ; Mikhael MA; Patlak CS
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):939-48. PubMed ID: 1658018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors.
    Groothuis DR; Warkne PC; Molnar P; Lapin GD; Mikhael MA
    J Neurosurg; 1990 Mar; 72(3):441-9. PubMed ID: 2106016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurements of capillary transport in human brain tumors by computed tomography.
    Groothuis DR; Vriesendorp FJ; Kupfer B; Warnke PC; Lapin GD; Kuruvilla A; Vick NA; Mikhael MA; Patlak CS
    Ann Neurol; 1991 Oct; 30(4):581-8. PubMed ID: 1789685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfelder CM; Borcich JK
    AJNR Am J Neuroradiol; 1984; 5(4):413-7. PubMed ID: 6431776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood volume and water extraction from cerebral parenchyma by hyperosmolar contrast media.
    Caillé JM; Billerey J; Renou AM; Constant P
    Neuroradiology; 1978; 16():579-82. PubMed ID: 745764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfeld CM; Borcich JK
    Invest Radiol; 1984; 19(6 Suppl):S312-6. PubMed ID: 6096290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum dose contrast bolus in computed angiotomography of the brain.
    Yamamoto Y; Satoh T; Sakurai M; Asari S; Sadamoto K
    J Comput Assist Tomogr; 1982 Jun; 6(3):575-85. PubMed ID: 7096703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.
    Nelson RC; Moyers JH; Chezmar JL; Hoel MJ; Jones EC; Peterson JE; Cork RD; Bernardino ME
    Radiology; 1991 Feb; 178(2):499-502. PubMed ID: 1987614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical evaluation of the dural sinuses in the region of the torcular herophili using three dimensional CT venography.
    Fukusumi A; Okudera T; Takahashi S; Taoka T; Sakamoto M; Nakagawa H; Takayama K; Kichikawa K; Iwasaki S
    Acad Radiol; 2010 Sep; 17(9):1103-11. PubMed ID: 20619699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of contrast agents in computed tomography scanning of the brain.
    Norman D; Enzmann DR; Newton TH
    J Comput Assist Tomogr; 1978 Jul; 2(3):319-21. PubMed ID: 263498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dose and time dependency of "CT clearance"].
    Kaltenborn HA; Klose KJ; Dexheimer C; von Steinijans
    Digitale Bilddiagn; 1989 Jun; 9(2):72-5. PubMed ID: 2752675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiphasic injection method for uniform prolonged vascular enhancement at CT angiography: pharmacokinetic analysis and experimental porcine model.
    Bae KT; Tran HQ; Heiken JP
    Radiology; 2000 Sep; 216(3):872-80. PubMed ID: 10966725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial CT angiography obtained from a cerebral CT perfusion examination.
    Gratama van Andel HA; Venema HW; Majoie CB; Den Heeten GJ; Grimbergen CA; Streekstra GJ
    Med Phys; 2009 Apr; 36(4):1074-85. PubMed ID: 19472612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption.
    Neuwelt EA; Maravilla KR; Frenkel EP; Barnett P; Hill S; Moore RJ
    Neurosurgery; 1980 Jan; 6(1):49-56. PubMed ID: 6153461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material: CT and MRI studies.
    Lantos G
    Neurology; 1989 Apr; 39(4):567-71. PubMed ID: 2927682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.